2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Metastatic Squamous Neck Cancer
Metastatic squamous neck cancer refers to cancer that originates in the squamous cells of the head and neck region and has spread to lymph nodes or distant organs. Research in this area focuses on improving treatment outcomes and understanding the molecular mechanisms driving metastasis. Scientists explore novel therapies such as immunotherapy, targeted therapy, and combination treatments to combat metastatic spread. Additionally, advancements in diagnostic techniques like genomic profiling aid in personalized treatment approaches, tailoring therapy to the individual patient's tumor characteristics. Early detection strategies and supportive care interventions also play crucial roles in managing metastatic squamous neck cancer, aiming to enhance patient quality of life and survival rates. By integrating multidisciplinary approaches, researchers strive to address the complexities of metastatic disease and improve patient outcomes.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China